Seung Hoon Han, Jihae Lee, Jeong Wook Kang, Heejin Kim, Dong Jin Lee, Jin Hwan Kim, Il Seok Park
{"title":"浅表 T1-2 原发性腮腺癌部分切除术与浅表或全腮腺切除术的比较","authors":"Seung Hoon Han, Jihae Lee, Jeong Wook Kang, Heejin Kim, Dong Jin Lee, Jin Hwan Kim, Il Seok Park","doi":"10.21053/ceo.2023.00014","DOIUrl":null,"url":null,"abstract":"Objective: This study aimed to compare the oncological outcomes of partial and superficial or total parotidectomies for superficial T1 or T2 primary parotid cancers and investigate their prognostic factors and recurrence patterns. Methods: The medical records of 77 patients with T1–2 primary parotid malignancies between May 2003 and March 2022 were retrospectively reviewed. Univariate and multivariate analyses were performed to evaluate the prognostic factors associated with overall survival, disease-free survival, and local and distant recurrences. Results: The average follow-up duration was 70.2 months (range,12–202 months). The 5-year overall and disease-free survival rates were 88.7% and 77.1%, respectively. Twenty-two patients underwent partial parotidectomy, and 55 underwent superficial or total parotidectomy. There were no significant differences in the disease recurrence ( p =0.320) and mortality rates ( p =0.884) of the partial and superficial or total parotidectomy groups. The mean duration of surgery was shorter and the overall complication rates were significantly lower for the partial group than for the superficial or total parotidectomy group ( p =0.049). Sixteen cases of recurrence occurred during the study period (20.8%). Univariate analyses showed that high-grade tumors ( p =0.006), lymphovascular invasion ( p =0.046), and regional lymph node metastasis ( p =0.010) were significant risk factors for disease recurrence. Multivariate analysis identified regional lymph node metastasis as an independent prognostic factor for disease recurrence ( p =0.027), and lymphovascular invasion as an independent prognostic factor for overall survival ( p =0.033). Conclusions: The conservative surgical approach of partial parotidectomy can yield oncologic outcomes comparable to superficial or total parotidectomies under careful patient","PeriodicalId":10318,"journal":{"name":"Clinical and Experimental Otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of partial and superficial or total parotidectomies for superficial T1-2 primary parotid cancers\",\"authors\":\"Seung Hoon Han, Jihae Lee, Jeong Wook Kang, Heejin Kim, Dong Jin Lee, Jin Hwan Kim, Il Seok Park\",\"doi\":\"10.21053/ceo.2023.00014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: This study aimed to compare the oncological outcomes of partial and superficial or total parotidectomies for superficial T1 or T2 primary parotid cancers and investigate their prognostic factors and recurrence patterns. Methods: The medical records of 77 patients with T1–2 primary parotid malignancies between May 2003 and March 2022 were retrospectively reviewed. Univariate and multivariate analyses were performed to evaluate the prognostic factors associated with overall survival, disease-free survival, and local and distant recurrences. Results: The average follow-up duration was 70.2 months (range,12–202 months). The 5-year overall and disease-free survival rates were 88.7% and 77.1%, respectively. Twenty-two patients underwent partial parotidectomy, and 55 underwent superficial or total parotidectomy. There were no significant differences in the disease recurrence ( p =0.320) and mortality rates ( p =0.884) of the partial and superficial or total parotidectomy groups. The mean duration of surgery was shorter and the overall complication rates were significantly lower for the partial group than for the superficial or total parotidectomy group ( p =0.049). Sixteen cases of recurrence occurred during the study period (20.8%). Univariate analyses showed that high-grade tumors ( p =0.006), lymphovascular invasion ( p =0.046), and regional lymph node metastasis ( p =0.010) were significant risk factors for disease recurrence. Multivariate analysis identified regional lymph node metastasis as an independent prognostic factor for disease recurrence ( p =0.027), and lymphovascular invasion as an independent prognostic factor for overall survival ( p =0.033). Conclusions: The conservative surgical approach of partial parotidectomy can yield oncologic outcomes comparable to superficial or total parotidectomies under careful patient\",\"PeriodicalId\":10318,\"journal\":{\"name\":\"Clinical and Experimental Otorhinolaryngology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2023-12-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Otorhinolaryngology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21053/ceo.2023.00014\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OTORHINOLARYNGOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Otorhinolaryngology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21053/ceo.2023.00014","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
Comparison of partial and superficial or total parotidectomies for superficial T1-2 primary parotid cancers
Objective: This study aimed to compare the oncological outcomes of partial and superficial or total parotidectomies for superficial T1 or T2 primary parotid cancers and investigate their prognostic factors and recurrence patterns. Methods: The medical records of 77 patients with T1–2 primary parotid malignancies between May 2003 and March 2022 were retrospectively reviewed. Univariate and multivariate analyses were performed to evaluate the prognostic factors associated with overall survival, disease-free survival, and local and distant recurrences. Results: The average follow-up duration was 70.2 months (range,12–202 months). The 5-year overall and disease-free survival rates were 88.7% and 77.1%, respectively. Twenty-two patients underwent partial parotidectomy, and 55 underwent superficial or total parotidectomy. There were no significant differences in the disease recurrence ( p =0.320) and mortality rates ( p =0.884) of the partial and superficial or total parotidectomy groups. The mean duration of surgery was shorter and the overall complication rates were significantly lower for the partial group than for the superficial or total parotidectomy group ( p =0.049). Sixteen cases of recurrence occurred during the study period (20.8%). Univariate analyses showed that high-grade tumors ( p =0.006), lymphovascular invasion ( p =0.046), and regional lymph node metastasis ( p =0.010) were significant risk factors for disease recurrence. Multivariate analysis identified regional lymph node metastasis as an independent prognostic factor for disease recurrence ( p =0.027), and lymphovascular invasion as an independent prognostic factor for overall survival ( p =0.033). Conclusions: The conservative surgical approach of partial parotidectomy can yield oncologic outcomes comparable to superficial or total parotidectomies under careful patient
期刊介绍:
Clinical and Experimental Otorhinolaryngology (Clin Exp Otorhinolaryngol, CEO) is an international peer-reviewed journal on recent developments in diagnosis and treatment of otorhinolaryngology-head and neck surgery and dedicated to the advancement of patient care in ear, nose, throat, head, and neck disorders. This journal publishes original articles relating to both clinical and basic researches, reviews, and clinical trials, encompassing the whole topics of otorhinolaryngology-head and neck surgery.
CEO was first issued in 2008 and this journal is published in English four times (the last day of February, May, August, and November) per year by the Korean Society of Otorhinolaryngology-Head and Neck Surgery. The Journal aims at publishing evidence-based, scientifically written articles from different disciplines of otorhinolaryngology field.
The readership contains clinical/basic research into current practice in otorhinolaryngology, audiology, speech pathology, head and neck oncology, plastic and reconstructive surgery. The readers are otolaryngologists, head and neck surgeons and oncologists, audiologists, and speech pathologists.